kjyworld.blog

https://www.scientificamerican.com/article/heart-and-kidney-diseases-plus-type-2-diabetes-may-be-one-illness-treatable

What Is CKM Syndrome?

Researchers found that type 2 diabetes, heart disease, and kidney disease all stem from the same biological mechanisms. The conditions are grouped under one name: cardio-kidney-metabolic syndrome (CKM), with “metabolic syndrome” referring to diabetes and obesity. CKM can be treated with new GLP-1 receptor agonist drugs such as Wegovy, Ozempic and Mounjaro.  GLP-1 agonists target the common pathways of CKM and reduce mortality and organ damage across all three systems. Conditions of CKM often occur together. For example, people with diabetes are two to four times more likely to develop heart disease than those without diabetes. The CKM framework captures a broader spectrum of disease states than traditional metabolic syndrome, enabling staged risk identification.


Should We Treat These Diseases as One? 

I believe the assertion about heart disease, kidney disease, and type 2 diabetes being intertwined is useful towards diagnosing patients in the future. 

The Evidence Behind the Theory

As of now, current GLP-1 and SGLT2 treatments are mostly injectable and costly. GLP-1 agents can cause nausea and vomiting, limiting tolerability for some patients. The article states that “although most of these drugs come only in injectable forms that can cause several hundred dollars a week, pill versions of some medications are up to approval”, confirming the production of more accessible forms of GLP-1 in production.

What This Means for the Future 

As new treatments become more affordable and available, the CKM approach could improve preventive care and help doctors treat multiple related conditions more effectively instead of managing them separately. 

Final Thoughts

In conclusion, CKM syndrome offers a useful—though still evolving—lens for preventive care across multiple organ systems. GLP-1 therapy shows promising results towards alleviating CKM syndrome. CKM should be treated as a single syndrome rather than three separate diseases.